Innovo Therapeutics

CA - San DiegoBiotechnology1 H-1B visas (FY2023)

Focus: Innovo Therapeutics is an AI-driven drug discovery biotech focused on immunology, headquartered in San Diego with an early-stage pipeline in Phase 1-2 development.

Immunology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Innovo Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Innovo Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

3 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

INV-101

Ulcerative Colitis

Phase 1

Clinical Trials (1)

NCT05844592First in Human, Single Ascending Dose Study

Phase 1

Help build intelligence for Innovo Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity at an AI-native drug discovery platform before clinical validation, with potential for outsized equity upside if programs advance
Focus on immunology addresses large therapeutic area with significant unmet needs in conditions like ulcerative colitis
San Diego location provides access to deep biotech talent network and venture ecosystem

Watch Out For

No revenue and minimal clinical data (only 3 active trials in Phase 1-2) create execution risk and potential for extended burn rate without clinical success
Zero hiring activity (0 active job postings) suggests either very early stage or potential funding constraints limiting team expansion

Generated by Claude from Innovo Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

INV-101

Healthy Volunteer

Phase 1

Clinical Trials (1)

NCT06938204Single Ascending Dose, Multiple Ascending Dose, Food Effect Study

Phase 1

INV-001

Scar

Phase 2

Clinical Trials (1)

NCT05838833Ointment to Prevent Scar After Thyroidectomy

Phase 2

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 3 clinical trials

Top TAs: Immunology

H-1B (2023): 1 approval

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Immunology

1 pipeline

Marketed

Pipeline

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub